Assessment of baseline bone turnover marker levels and response to risedronate treatment: Data from a Japanese phase III trial.

Bone Rep · 2020 · PMC7240327 · PMID 32462056

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Our results also indicated this, although the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.